SEC Form 4 · accession 0001410384-17-000160
Q2 Holdings, Inc. · QTWO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Breeden
Officer — EVP, Operations
Period of report
Nov 17, 2017
Accepted (ET)
Nov 17, 2017 · 6:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410384
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 17, 2017 | M | 10,000 | $8.35 | A | 64,694 | D | |
| Common StockF2 | Nov 17, 2017 | S | 10,000 | $43.14 | D | 54,694 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $8.35 | Nov 17, 2017 | M | 10,000 | D | Jan 24, 2016 | Jan 24, 2021 | Common Stock | 10,000 | 27,717 | D |
Explanation of responses
- F1Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.60 to $43.925 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3This option grant vested as to 1/4 of the total option grant on January 24, 2016, and thereafter as to 1/32 of the total option grant monthly. The option grant becomes exercisable as it vests.